Filing Flows › Bio-Techne (TECH) › R&D spending
Bio-Techne (TECH) R&D spending by quarter
Bio-Techne's R&D spending was $26.3M in Q1 FY27 (first quarter fiscal 2027), +10% from Q4 FY26. Over the last 7 quarters it ranged from $23.1M (Q2 FY26) to $26.3M (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $26.3M | +10% | +9% |
| Q4 FY26 | $23.9M | +2% | -8% |
| Q3 FY26 | $23.5M | +1% | -5% |
| Q2 FY26 | $23.1M | -5% | — |
| Q1 FY26 | $24.2M | -7% | — |
| Q4 FY25 | $26.0M | +6% | — |
| Q3 FY25 | $24.6M | — | — |
Q1 FY27 at a glance
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Techne's R&D spending?
Bio-Techne's R&D spending was $26.3M in Q1 FY27 (first quarter fiscal 2027), +10% from Q4 FY26.
How has Bio-Techne's R&D spending changed?
Over the last 7 quarters it ranged from $23.1M (Q2 FY26) to $26.3M (Q1 FY27).